Strategic Reaction to Environmental Regulation: The Combined Effect on Earnings Management and Environmental Information Disclosure
European Financial Management · 2025-11 · 31 (5) · 1894-1911
DOI: 10.1111/eufm.12566 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Financial Management, online erschienen am 25.05.2025. Verfasst von Hao Gao und 3 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
We investigate firms' strategic reactions to environmental regulation enforcing China's New Environmental Protection Law (NEPL). We find that in the short term, polluting firms conduct more earnings management and the effect is stronger for firms under performance pressure. In the long term, environmental regulation facilitates environmental information disclosure, which is strengthened by better external governance. We also find that NEPL enforcement has an immediate negative effect on firm value but decreases firms' long‐horizon price crash risk. Our study highlights the combined effects of environmental regulation on firm decisions and outcomes in different horizons.
Zitieren
APA
Gao, H., Qu, Y., Wang, C., & Wu, W. (2025). Strategic Reaction to Environmental Regulation: The Combined Effect on Earnings Management and Environmental Information Disclosure. European Financial Management, 31(5), 1894-1911. https://doi.org/10.1111/eufm.12566
Vancouver
Gao H, Qu Y, Wang C, Wu W. Strategic Reaction to Environmental Regulation: The Combined Effect on Earnings Management and Environmental Information Disclosure. European Financial Management. 2025;31(5):1894-1911. doi:10.1111/eufm.12566
BibTeX
@article{Gao2025,
author = {Gao, Hao and Qu, Yuanyu and Wang, Chenyu and Wu, Weixing},
title = {Strategic Reaction to Environmental Regulation: The Combined Effect on Earnings Management and Environmental Information Disclosure},
journal = {European Financial Management},
year = {2025},
volume = {31},
number = {5},
pages = {1894--1911},
doi = {10.1111/eufm.12566}
}
EUVIMED